Panagiota Pervanidou1, Giorgos Chouliaras1, Athanassios Akalestos2, Despoina Bastaki1, Filia Apostolakou2, Ioannis Papassotiriou2, George P Chrousos3. 1. Childhood Obesity Clinic, First Department of Pediatrics, University of Athens Medical School, Aghia Sophia Children's Hospital, Athens, Greece. 2. Department of Clinical Biochemistry, Aghia Sophia Children's Hospital; Athens, Greece. 3. Childhood Obesity Clinic, First Department of Pediatrics, University of Athens Medical School, Aghia Sophia Children's Hospital, Athens, Greece, Department of Biochemistry, King Abdulaziz University, Jeddah, KSA.
Abstract
OBJECTIVE: Childhood obesity and the Metabolic Syndrome (MetS) are associated with an increased risk for early onset endothelial dysfunction and atherosclerosis. Placental growth factor (PlGF), a member of the vascular endothelial growth factor family, plays an important role in atherosclerosis by stimulating angiogenesis and atherogenic migration of monocytes/macrophages into the arterial wall. The aim of this study was to investigate differences in circulating PlGF concentrations between children with obesity/metabolic syndrome and non-obese children. We have previously shown increased high-sensitivity troponin (hs-TnT) concentrations in children with MetS from the same cohort. DESIGN: Fifty-seven obese (49 without and 8 with MetS) and 25 non-obese children (controls) were assessed at the Childhood Obesity Clinic of our Department. Obesity was defined using the IOTF criteria. MetS was defined based on the IDF criteria. PlGF was measured using electrochemiluminescence methodology. RESULTS: Mean PIGF concentrations of obese children were significantly higher (p=0.048) compared with those of the controls. Analysis of the three groups, the οbese (without MetS), the MetS and the control, demonstrated a significant difference in PlGF concentrations (p=0.035). Subgroup analysis revealed increased PlGF concentrations in children with the MetS compared to the controls (p=0.009). Troponin had a significant positive correlation with PlGF overall (p=0.003) and in the obese group (p=0.046). CONCLUSIONS: Increased serum concentrations of PlGF, a biomarker of angiogenesis, are found in obese children with the MetS compared to non-obese controls, whereas PlGF correlated positively with troponin. Longitudinal studies may reveal the prognostic role of this biomarker in the progression of atherosclerosis in obese children with the MetS.
OBJECTIVE: Childhood obesity and the Metabolic Syndrome (MetS) are associated with an increased risk for early onset endothelial dysfunction and atherosclerosis. Placental growth factor (PlGF), a member of the vascular endothelial growth factor family, plays an important role in atherosclerosis by stimulating angiogenesis and atherogenic migration of monocytes/macrophages into the arterial wall. The aim of this study was to investigate differences in circulating PlGF concentrations between children with obesity/metabolic syndrome and non-obesechildren. We have previously shown increased high-sensitivity troponin (hs-TnT) concentrations in children with MetS from the same cohort. DESIGN: Fifty-seven obese (49 without and 8 with MetS) and 25 non-obesechildren (controls) were assessed at the Childhood Obesity Clinic of our Department. Obesity was defined using the IOTF criteria. MetS was defined based on the IDF criteria. PlGF was measured using electrochemiluminescence methodology. RESULTS: Mean PIGF concentrations of obesechildren were significantly higher (p=0.048) compared with those of the controls. Analysis of the three groups, the οbese (without MetS), the MetS and the control, demonstrated a significant difference in PlGF concentrations (p=0.035). Subgroup analysis revealed increased PlGF concentrations in children with the MetS compared to the controls (p=0.009). Troponin had a significant positive correlation with PlGF overall (p=0.003) and in the obese group (p=0.046). CONCLUSIONS: Increased serum concentrations of PlGF, a biomarker of angiogenesis, are found in obesechildren with the MetS compared to non-obese controls, whereas PlGF correlated positively with troponin. Longitudinal studies may reveal the prognostic role of this biomarker in the progression of atherosclerosis in obesechildren with the MetS.
Authors: Joao Incio; Josh Tam; Nuh N Rahbari; Priya Suboj; Dan T McManus; Shan M Chin; Trupti D Vardam; Ana Batista; Suboj Babykutty; Keehoon Jung; Anna Khachatryan; Tai Hato; Jennifer A Ligibel; Ian E Krop; Stefan B Puchner; Christopher L Schlett; Udo Hoffmman; Marek Ancukiewicz; Masabumi Shibuya; Peter Carmeliet; Raquel Soares; Dan G Duda; Rakesh K Jain; Dai Fukumura Journal: Clin Cancer Res Date: 2016-02-09 Impact factor: 12.531
Authors: Angela C Flynn; John M D Thompson; Kathryn V Dalrymple; Clare Wall; Shahina Begum; Jaijus Pallippadan Johny; Wayne S Cutfield; Robyn North; Lesley M E McCowan; Keith M Godfrey; Edwin A Mitchell; Lucilla Poston Journal: Br J Nutr Date: 2020-02-26 Impact factor: 3.718
Authors: Sebastian Schölch; Andreas Bogner; Ulrich Bork; Mohammad Rahbari; Balázs Győrffy; Martin Schneider; Christoph Reissfelder; Jürgen Weitz; Nuh N Rahbari Journal: Sci Rep Date: 2019-07-29 Impact factor: 4.379
Authors: Benjamin H L Harris; Valentine M Macaulay; David A Harris; Paul Klenerman; Fredrik Karpe; Simon R Lord; Adrian L Harris; Francesca M Buffa Journal: Cancer Metastasis Rev Date: 2022-08-30 Impact factor: 9.237